# Tolvaptan Versus Fluid Restriction in SIADH

> **NCT04119206** · — · COMPLETED · sponsor: **University of Erlangen-Nürnberg Medical School** · enrollment: 334 (actual)

## Conditions studied

- Hyponatremia
- Syndrome of Inappropriate ADH (SIADH) Secretion
- Pituitary

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04119206
- **Lead sponsor:** University of Erlangen-Nürnberg Medical School
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01-01
- **Primary completion:** 2013-12-31
- **Final completion:** 2013-12-31
- **Target enrollment:** 334 (ACTUAL)
- **Last updated:** 2019-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04119206

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04119206, "Tolvaptan Versus Fluid Restriction in SIADH". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04119206. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*